Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Thomas, McNerney & Partners II, LLC Create: Alert

All | News | Filings
Date FiledTypeDescription
04/25/2022 4/A THOMAS MCNERNEY & PARTNERS LP (10% Owner) has filed a Form 4 on Clarus Therapeutics Holdings, Inc.
Txns: Sold 1,663,126 shares @ $2.53, valued at $4.2M
Sold 2,061,685 shares @ $2.53, valued at $5.2M
Sold 5,722 shares @ $2.53, valued at $14.5k
Sold 13,630 shares @ $2.53, valued at $34.5k
Sold 1,164 shares @ $2.53, valued at $2.9k
Sold 7,585 shares @ $2.53, valued at $19.2k
04/21/2022 4 THOMAS MCNERNEY & PARTNERS LP (10% Owner) has filed a Form 4 on CLARUS THERAPEUTICS INC
Txns: Sold 1,663,126 shares @ $2.53, valued at $4.2M
Sold 2,061,685 shares @ $2.53, valued at $5.2M
Sold 5,722 shares @ $2.53, valued at $14.5k
Sold 13,630 shares @ $2.53, valued at $34.5k
Sold 1,164 shares @ $2.53, valued at $2.9k
Sold 7,585 shares @ $2.53, valued at $19.2k
09/21/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
04/22/2019 4 Thomas, McNerney & Partners II L.P. (10% Owner) has filed a Form 4 on CAS MEDICAL SYSTEMS INC
Txns: Converted 6,802,834 shares @ $2.389, valued at $16.3M
Converted 24,125 shares @ $2.389, valued at $57.6k
Converted 71,075 shares @ $2.389, valued at $169.8k
Converted 3,906,315 shares @ $2.389, valued at $9.3M
Converted 13,881 shares @ $2.389, valued at $33.2k
Converted 40,772 shares @ $2.389, valued at $97.4k
Disposed/sold 12,300,186 shares @ $2.45, valued at $30.1M
Disposed/sold 43,944 shares @ $2.45, valued at $107.7k
Disposed/sold 119,872 shares @ $2.45, valued at $293.7k
Converted 94,182 convertible preferred @ $0
Converted 334 convertible preferred @ $0
02/10/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
12/06/2016 4 Thomas, McNerney & Partners II L.P. (10% Owner) has filed a Form 4 on Invitae Corp
05/07/2015 4 Thomas, McNerney & Partners II, LLC (10% Owner) has filed a Form 4 on Auspex Pharmaceuticals, Inc.
Txns: Unknown transaction of 4,835,731 shares @ $0
02/18/2015 4 Form 4 - Statement of changes in beneficial ownership of securities
02/13/2015 4 Thomas, McNerney & Partners II L.P. (10% Owner) has filed a Form 4 on CAS MEDICAL SYSTEMS INC
Txns: Bought 1,591,037 shares @ $1.3, valued at $2.1M
Bought 8,025 shares @ $1.3, valued at $10.4k
Bought 5,938 shares @ $1.3, valued at $7.7k
01/30/2015 4 Thomas, McNerney & Partners II, LLC (10% Owner) has filed a Form 4 on Auspex Pharmaceuticals, Inc.
Txns: Sold 730,000 shares @ $53.11, valued at $38.8M
01/12/2015 4 Thomas, McNerney & Partners II, LLC (10% Owner) has filed a Form 4 on Auspex Pharmaceuticals, Inc.
Txns: Disposed/sold 24,008 shares @ $51.574, valued at $1.2M
Exercised 59,277 warrants @ $3.879, valued at $229.9k
Exercised 169,630 warrants @ $3.879, valued at $658k
Exercised 90,228 warrants @ $3.879, valued at $350k
10/14/2014 4 Thomas, McNerney & Partners II, LLC (10% Owner) has filed a Form 4 on Auspex Pharmaceuticals, Inc.
10/01/2014 4 Thomas, McNerney & Partners II, LLC (10% Owner) has filed a Form 4 on Auspex Pharmaceuticals, Inc.
Txns: Disposed/sold 12,226 shares @ $20.598, valued at $251.8k
Disposed/sold 46 shares @ $20.598, valued at $947.5
Exercised 64,918 warrants @ $3.879, valued at $251.8k
Exercised 243 warrants @ $3.879, valued at $942.6
10/01/2014 4 Thomas, McNerney & Partners II, LLC (10% Owner) has filed a Form 4 on Auspex Pharmaceuticals, Inc.
Txns: Converted 5,031,092 shares @ $0
Bought 82,475 shares @ $12, valued at $989.7k
Converted 2,266,186 convertible preferred @ $0
Converted 7,474,419 convertible preferred @ $0
Converted 11,792,529 convertible preferred @ $0
Converted 1,106,779 convertible preferred @ $0
Converted 293,230 options to buy @ $0.862, valued at $252.8k
Converted 65,161 warrants @ $3.879, valued at $252.8k
Converted 267,899 options to buy @ $0.862, valued at $230.9k
Converted 59,532 warrants @ $3.879, valued at $230.9k
Converted 264,003 options to buy @ $0.862, valued at $227.6k
07/17/2013 4/A Thomas, McNerney & Partners II L.P. (10% Owner) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns: Acquired 687,176 shares @ $6, valued at $4.1M
Acquired 1,751,393 shares @ $6, valued at $10.5M
Granted 25,000 options to buy @ $4, valued at $100k
Granted 31,835 options to buy @ $4.24, valued at $135k
Granted 100,000 options to buy @ $0.11, valued at $11k
Granted 25,000 options to buy @ $0.22, valued at $5.5k
Granted 25,000 options to buy @ $0.22, valued at $5.5k
Granted 161,855 warrants @ $0.08, valued at $12.9k
Granted 161,855 warrants @ $0.08, valued at $12.9k
01/14/2013 3 Form 3 - Initial statement of beneficial ownership of securities
11/30/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
11/29/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
11/22/2010 3 Form 3 - Initial statement of beneficial ownership of securities
11/22/2010 3 Form 3 - Initial statement of beneficial ownership of securities
11/22/2010 3 THOMAS MCNERNEY & PARTNERS LP (10% Owner) has filed a Form 3 on ZOGENIX, INC.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy